BioNTech stock popped Friday after the company asked European regulators to authorize its Pfizer-partnered Covid vaccine for teenagers. Shares are now extended from a recent breakout.
Breakout Success: BioNTech Stock Pops On Covid Vaccine For Teens
2021-04-30T17:16:52-04:00April 30th, 2021|